Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2005

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
GLP compliance:
yes
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
3-cyclopentyl-1H-indole-6-carboxylic acid
Cas Number:
494799-36-9
Molecular formula:
C14 H15 N O2
IUPAC Name:
3-cyclopentyl-1H-indole-6-carboxylic acid
Test material form:
solid: particulate/powder
Remarks:
migrated information: powder
Details on test material:
- Name of test material (as cited in study report): CD 6002 SE
- Analytical purity: 99.7 %
- Storage : room temperature and ambient humidity
- Lot/batch No.: TSA-05-003

Method

Species / strain
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
Metabolic activation:
with and without
Test concentrations with justification for top dose:
TA 98, TA 100 with and without metabolic activation : 10, 20, 39, 78, 156, 313, 625, 1250, 2500, 5000 µg/plate
TA 1535, TA 1537 WP2 uvrA with and without metabolic activation: 31, 63, 125, 250, 500, 1000 µg/plate
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: DMSO;
Controls
Negative solvent / vehicle controls:
yes
Positive controls:
yes
Positive control substance:
9-aminoacridine
2-nitrofluorene
sodium azide
methylmethanesulfonate
other: 2-Aminoanthracene
Details on test system and experimental conditions:
METHOD OF APPLICATION: in agar (plate incorporation)


Evaluation criteria:
S.typhimurium strains TA 1535, TA 1537, TA 98 : An increase in mean revertant numbers to greater or equal to 3x the concurrent vehicle control
mean revertant number or 20, whichever is greater.
S. typhimurium strain TA 100 and E.coli WP2 uvrA :An increase in mean revertant numbers to greater or equal to 2x the concurrent vehicle control
revertant number.
A positive response typically includes a reproducible dose-related significant increase in mean revertant numbers that my be reduced at high dose
levels due to cytotoxicity.
These criteria are guidelines for evaluation and may be modulated by other biological factors that are discussed within the context of the report.

Results and discussion

Test results
Species / strain:
S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
not specified
Vehicle controls validity:
valid
Untreated negative controls validity:
not specified
Positive controls validity:
valid
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information):
negative

CD 6002 was non-mutagenic when tested in Salmonella typhimurium strains, TA 1535, TA 1537, TA 98, TA 100 and Escherichia coli WP2 uvrA (pKM101) in the absence and presence of an activation system over a range of doses that included toxic levels.
It is concluded that CD 6002 SE was non-mutagenic under the conditions in this assay.
Executive summary:

The mutagenic potential of CD 6002 SE was investigated in a study with Salmonella typhimurium strains TA 1535, TA 1537, TA 98, TA 100 and Escherichia coli WP2 uvrA.

The test were conducted between October 11,2005 and October 13,2005 using the plate incorporation method in presence and absence of an Aroclor 1254 -induced rat liver preparation and co-factors (S9 mix ) required for mixed function oxidase activity. Each dose level and control was plated triplicate.

The bacteria, Salmonella typhimurium strains TA 100 and TA 98 were treated initially with dose levels of 10, 20, 39, 78, 156, 313, 625, 1250, 2500 and 5000 µg/plate of CD 6002 SE in presence and absence of an activation system.

The test article precipitated at the two highest dose levels, 2500 and 5000 µg/plate, upon addition to the aqueous solution. In TA 98 there was a reduction in colony numbers and/or a thin lawn at dose levels greater or equal to 12500 µg/plate in presence and absence of an activation system. In TA 100 there was a reduction in colony numbers and/or a thin lawn at dose levels greater than or equal to 625 µg/plate in the absence of an activation system and at dose level greater than or equal to 313 µg/plate in the presence of an activation system. These observations are indicative of toxicity.

CD 6002 SE was then tested at dose levels of 31, 63, 125, 250, 500 and 1000 µg/plate in Salmonella typhimurium TA 1535 and

TA 1537 and Escherichia coli WP2 uvrA (pKM101) with and without S9 mix.

There was evidence of a reduction in colonies in TA 1535, TA 1537 of the highest dose level, 1000 µg/plate in both absence and presence of an activation system. There was no evidence of a significant increase in the number of colonies in any of the trains, when tested in either presence or absence of an S9 mixture.

CD 6002 was non-mutagenic when tested in Salmonella typhimurium strains, TA 1535, TA 1537, TA 98, TA 100 and Escherichia coli WP2 uvrA (pKm101) in the presence or absence of an activation system over a range of doses that included toxic levels.